Visceral leishmaniasis (VL) is caused by Leishmania donovani and Leishmania infantum.
The burden of VL is concentrated in tropical and subtropical areas; however, HIV infection …

Leishmania is a genus of protozoan parasites that give rise to a range of diseases called
Leishmaniasis that affects annually an estimated 1.3 million people from 88 countries …

Background HIV infection promotes the expansion of immunosuppressive regulatory T-cells
(Tregs), contributing to immune dysfunction, tissue fibrosis and disease progression. Early …

No licensed human vaccines are currently available against any parasitic disease including
leishmaniasis. Several antileishmanial vaccine formulations have been tested in various …

The CCR5 molecule was reported in 1996 as the main HIV‐1 co‐receptor. In that same year,
the CCR5Δ32 genetic variant was described as a strong protective factor against HIV‐1 …

Leishmania and HIV coinfection is a major health problem in more than 35 countries
worldwide. The impaired immune function of visceral leishmaniasis/HIV-coinfected patients …

Background Atherosclerosis (AS) is a chronic inflammatory disease that might induce severe
cardiovascular events, such as myocardial infarction and cerebral infarction. These risk …

Relationship between CCR5+FoxP3+ Treg cells and forced expiratory volume in 1 s, peak
expiratory flow in patients with severe as Page 1 Advances in Dermatology and Allergology 2 …

We report a case of a severe visceral leishmaniasis revealing an HIV-1 infection presenting
as an acute primary infection. A young French man living in Paris with history of unprotected …

A leishmaniose visceral (LV), quando associada ao vírus da imunodeficiência humana
(HIV), torna-se uma doença mais grave, com aumento na letalidade dos indivíduos …